139th Day Of Lockdown

Maharashtra51533235171017757 Tamil Nadu2969012386384927 Andhra Pradesh2278601387122036 Karnataka178087939083198 Delhi1454271305874111 Uttar Pradesh122609726502069 West Bengal95554671202059 Bihar7972051315429 Telangana7949555999627 Gujarat71064542382652 Assam5883842326145 Rajasthan5249738235789 Odisha4592731785321 Haryana4163534781483 Madhya Pradesh3902529020996 Kerala3433121832109 Jammu and Kashmir2489717003472 Punjab2390315319586 Jharkhand185168998177 Chhatisgarh12148880996 Uttarakhand96326134125 Goa871259575 Tripura6161417641 Puducherry5382320187 Manipur3752204411 Himachal Pradesh3371218114 Nagaland27819048 Arunachal Pradesh215514823 Chandigarh151590425 Meghalaya10624906 Sikkim8664971 Mizoram6082980
World America 01 Jul 2020 US hoards global sto ...

US hoards global stock of COVID-19 drug remdesivir

DECCAN CHRONICLE. | DC WEB DESK
Published Jul 1, 2020, 6:46 pm IST
Updated Jul 2, 2020, 8:16 am IST
The Trump administration has now bought more than 5,00,000 doses, the entire batch produced for July and 90% of August and September
Remdesivir, developed by Gilead Sciences, is the first drug approved by licensing authorities in the US to treat COVID-19. AP Photo
 Remdesivir, developed by Gilead Sciences, is the first drug approved by licensing authorities in the US to treat COVID-19. AP Photo

The Trump administration has now bought more than 500,000 doses of the remdesivir drug, which is the entire batch produced for July and 90% of August and September.

The United States has bought almost the entire global supply of remdesivir, leaving nothing for the rest of the world, The Guardian reports. As of now, remdesivir is one of the only two drugs that has been proven to work against the virus that causes COVID-19.

 

The news and its wider implications have created havoc in the international community. In the event of the development of a vaccine for coronavirus, this could mean the US, with its money and power, would attempt to buy it entirely as well.

The Trump administration has now bought more than 5,00,000 doses, which is the entire batch produced for July and 90% of August and September.

Remdesivir, developed by Gilead Sciences, is the first drug approved by licensing authorities in the US to treat COVID-19.  The drug has been authorised for emergency use in countries like India, Singapore, and approved for use in Japan for people with severe symptoms.

 

The drug has shown potential to help people recover faster from the disease. The first 1,40,000 doses supplied for the purpose of drug trials around the world, have been used up.

Gilead Sciences holds the patent and complete authority to produce and distribute remdesivir, which was first developed as a failed attempt for curing Ebola is with Gilead Sciences.

The cost is around $3,200 per treatment of six doses, according to the US government statement.

Trump's current move to hoard up all of remdesivir has stirred international protest in the background of criticism over Trump administration's handling of the pandemic.

 

The US has recorded more than 2.5 million confirmed cases of Covid-19. Some states lifted restrictions only to enforce a clampdown again.

A month ago, France had raised its voice against Sanofi's announcement that US would be one of the first to receive if they developed a cure for COVID-29, considering the monetary investment.

Dailymail reports that Britain currently gets its supplies of remdesivir for free because of a Gilead deal to donate 1.5million vials across the world.

Gilead earlier this week announced it would charge the governments of developed countries $390 (£320) per vial of remdesivir.

 

Dexamethasone, a steroid that has existed for decades, is the other drug proven to reduce the death rate among hospitalised patients needing oxygen.

...




ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT